Satoki Nakamura

1.3k citations

68 papers · 1.0k indexed · h-index 21

Co-authors: Kazunori Ohnishi Kaori Shinjo Kazuyuki Shigeno Kensuke Naito Akihiro Takeshita Ryuzo Ohno Naruhiko Sahara Shinya Fujisawa
Topics: Chronic Myeloid Leukemia Treatments (11 papers)Organophosphorus compounds synthesis (9 papers)Acute Myeloid Leukemia Research (9 papers)
Cited by: Hematology Molecular Biology Oncology
Journals: Journal of Biological Chemistry Blood PLoS ONE
Partner nations: Japan Belgium United Kingdom

In The Last Decade

Satoki Nakamura

68 papers receiving 1.0k citations

Peers

Countries citing papers authored by Satoki Nakamura

Since Specialization

Citations

This map shows the geographic impact of Satoki Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoki Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoki Nakamura more than expected).

Fields of papers citing papers by Satoki Nakamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoki Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoki Nakamura. The network helps show where Satoki Nakamura may publish in the future.

Co-authorship network of co-authors of Satoki Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Satoki Nakamura. A scholar is included among the top collaborators of Satoki Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoki Nakamura. Satoki Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes 2020 ·Scientific Reports ·(unknown),Shuichiro Higo,(unknown),(unknown),Takumi Kondo,Takamaru Ishizu,Tomoaki Higo,Satoki Nakamura,(unknown),(unknown),Hiroyuki Inoue,Daisuke Motooka,Daisuke Okuzaki,Seiji Takashima,Shigeru Miyagawa,Yoshiki Sawa,Shungo Hikoso,Yasushi Sakata	20
2	WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma 2017 ·Molecular Carcinogenesis ·Kazuya Shinmura,(unknown),Yuichi Kawanishi,Hisaki Igarashi,Yusuke Inoue,Katsuhiro Yoshimura,Satoki Nakamura,(unknown),Kazuhito Funai,Masayuki Tanahashi,Hiroshi Niwa,Hiroshi Ogawa,Haruhiko Sugimura	18
3	Mutation Spectrum Induced by 8‐Bromoguanine, a Base Damaged by Reactive Brominating Species, in Human Cells 2017 ·Oxidative Medicine and Cellular Longevity ·Kazuya Shinmura,(unknown),Masanori Goto,Tao Hong,Yusuke Inoue,Satoki Nakamura,(unknown),(unknown),Haruhiko Sugimura	5
4	CLCA2 as a Novel Immunohistochemical Marker for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung 2014 ·Disease Markers ·Kazuya Shinmura,Hisaki Igarashi,(unknown),Yuichi Kawanishi,Yusuke Inoue,Satoki Nakamura,Hiroshi Ogawa,(unknown),Akikazu Kawase,Kazuhito Funai,Haruhiko Sugimura	24
5	Impaired 8-Hydroxyguanine Repair Activity of MUTYH Variant p.Arg109Trp Found in a Japanese Patient with Early-Onset Colorectal Cancer 2014 ·Oxidative Medicine and Cellular Longevity ·Kazuya Shinmura,Masanori Goto,Tao Hong,(unknown),Rie Suzuki,Satoki Nakamura,Tomonari Matsuda,Guang Yin,Makiko Morita,Suminori Kono,Haruhiko Sugimura	8
6	The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer 2012 ·Journal of Translational Medicine ·Hiroko Natsume,Kazuya Shinmura,Tao Hong,Hisaki Igarashi,Masaya Suzuki,Kiyoko Nagura,Masanori Goto,Hidetaka Yamada,Matsuyoshi Maeda,Hiroyuki Konno,Satoki Nakamura,Haruhiko Sugimura	20
7	Down‐regulation of Thanatos‐associated protein 11 by BCR‐ABL promotes CML cell proliferation through c‐Myc expression 2011 ·International Journal of Cancer ·Satoki Nakamura,Daisuke Yokota,Lin Tan,(unknown),(unknown),(unknown),Kazuyuki Shigeno,Kiyoshi Shibata,Shinya Fujisawa,Kazunori Ohnishi	22
8	GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms 2010 ·Cell Division ·Kyoko Kitagawa,Yojiro Kotake,Yoshihiro Hiramatsu,Ning Liu,Sayuri Suzuki,Satoki Nakamura,Akira Kikuchi,Masatoshi Kitagawa	14
9	Activation of the Interferon Pathway in Peripheral Blood of Patients with Sjögren’s Syndrome 2010 ·The Journal of Rheumatology ·(unknown),(unknown),Kumiko Shimoyama,Daisuke Suzuki,Satoki Nakamura,Hideharu Hayashi,Noriyoshi Ogawa	46
10	Preparation And Characterization Of Phospholanes And Phospha Sugars As Novel Anti-Cancer Agents 2009 ·Heterocyclic Communications ·Satoru Ito,Mitsuji Yamashita,(unknown),Michio Fujie,(unknown),(unknown),(unknown),Kasthuraiah Maddali,Satoki Nakamura,(unknown),(unknown),Junko Yamashita,(unknown),Gang Yu,Tatsuo Oshikawa	8
11	CMC‐544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B‐cell chronic lymphocytic leukaemia and lymphoma 2009 ·British Journal of Haematology ·Akihiro Takeshita,Kaori Shinjo,(unknown),Takaaki Ono,(unknown),Hirotaka Matsui,Kazuyuki Shigeno,Satoki Nakamura,Tadasu Tobita,Masato Maekawa,Kazunori Ohnishi,Yoshikazu Sugimoto,Hitoshi Kiyoi,Tomoki Naoe,Ryuzo Ohno	47
12	HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells 2008 ·Leukemia Research ·(unknown),Satoki Nakamura,Keiji Okinaka,(unknown),Takaaki Ono,Kazuyuki Shigeno,Kaori Shinjo,Kazunori Ohnishi	11
13	KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells 2008 ·Leukemia Research ·Satoki Nakamura,Keiji Okinaka,(unknown),Takaaki Ono,(unknown),Kazuyuki Shigeno,Shinya Fujisawa,Kaori Shinjo,Kazunori Ohnishi	19
14	Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide 2006 ·Cancer Chemotherapy and Pharmacology ·Shinya Fujisawa,Ryuzo Ohno,Kazuyuki Shigeno,Naruhiko Sahara,Satoki Nakamura,Kensuke Naito,Miki Kobayashi,Kaori Shinjo,Akihiro Takeshita,Yoshinari Suzuki,Hisakuni Hashimoto,Kenji Kinoshita,(unknown),Toshikazu Kaise,Kazunori Ohnishi	49
15	Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56− and CD56+ multiple myeloma cells 2006 ·Experimental Hematology ·Naruhiko Sahara,Akihiro Takeshita,Takaaki Ono,(unknown),Miki Kobayashi,Kazuyuki Shigeno,Satoki Nakamura,Kaori Shinjo,Kensuke Naito,Kiyoshi Shibata,Takemi Otsuki,Hideharu Hayashi,Kazunori Ohnishi	12
16	Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies 2005 ·International Journal of Hematology ·Kazuyuki Shigeno,Kensuke Naito,Naruhiko Sahara,Miki Kobayashi,Satoki Nakamura,(unknown),Kaori Shinjo,Akihiro Takeshita,Ryuzo Ohno,Kazunori Ohnishi	80
17	Phenylarsine Oxide (PAO) More Intensely Induces Apoptosis in Acute Promyelocytic Leukemia and As₂O₃-Resistant APL Cell Lines than As₂O₃by Activating the Mitochondrial Pathway 2004 ·Leukemia & lymphoma ·Naruhiko Sahara,Akihiro Takeshita,Miki Kobayashi,Kazuyuki Shigeno,Satoki Nakamura,Kaori Shinjo,Kensuke Naito,Masato Maekawa,Toshinobu Horii,Kazunori Ohnishi,Kunio Kitamura,Tomoki Naoe,Hideharu Hayashi,Ryuzo Ohno	16
18	Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias 2003 ·Cancer Letters ·Kazuyuki Shigeno,Hitoshi Yoshida,Ling Pan,(unknown),Shinya Fujisawa,Kensuke Naito,Satoki Nakamura,Kaori Shinjo,Akihiro Takeshita,Ryuzo Ohno,Kazunori Ohnishi	32
19	Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down‐regulation of Bcl‐2 Expression and Modulation of Promyelocytic Leukemia Protein 2000 ·Japanese Journal of Cancer Research ·Wen Jie Zhang,Kazunori Ohnishi,Hitoshi Yoshida,Ling Pan,(unknown),(unknown),(unknown),Kazuyuki Shigeno,Shinya Fujisawa,Kensuke Naito,Satoki Nakamura,Kaori Shinjo,Akihiro Takeshita,Ryuzo Ohno	7
20	Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF 2000 ·PubMed ·Satoki Nakamura,Kazunori Ohnishi,Hitoshi Yoshida,Kaori Shinjo,Akihiro Takeshita,Kaoru Tohyama,Ryuzo Ohno,Yukio Koide	17

About Satoki Nakamura

Satoki Nakamura is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics, having authored 68 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Organophosphorus compounds synthesis (9 papers) and Acute Myeloid Leukemia Research (9 papers). The work is most often cited by research in Hematology (243 citations), Molecular Biology (606 citations) and Oncology (216 citations). Satoki Nakamura has collaborated with scholars based in Japan, Belgium and United Kingdom. Frequent co-authors include Kazunori Ohnishi, Kaori Shinjo, Kazuyuki Shigeno, Kensuke Naito, Akihiro Takeshita, Ryuzo Ohno, Naruhiko Sahara, Shinya Fujisawa, Miki Kobayashi and Haruhiko Sugimura. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact